MidWestOne Financial Group’s Harmony Biosciences HRMY Stock Holding History

MidWestOne Financial Group’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$319K	Buy	+8,526	New	+$280K	0.04%	245

Other funds holding HRMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MidWestOne Financial Group's HRMY Position: Q4 2025 in Review

MidWestOne Financial Group opened a new position in Harmony Biosciences (HRMY) in Q4 2025: 8,526 shares worth $319K. The stake represents 0.04% of the portfolio and ranks #245 among its holdings.

323 funds tracked by Wall St. Rank hold HRMY as of Q4 2025.

MidWestOne Financial Group held 8,526 shares of Harmony Biosciences worth $319K as of Q4 2025.
Harmony Biosciences was a new MidWestOne Financial Group position in Q4 2025.
Harmony Biosciences made up 0.04% of MidWestOne Financial Group's portfolio in Q4 2025, its #245 holding.
323 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2025.

Based on MidWestOne Financial Group's 13F filing for Q4 2025, filed 12 Feb 2026.